Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
827.00    10.00 (1.22%)
Bid:
825.00
Ask:
827.00
Spread: 2.00 (0.242%)
Market Cap: £1.15b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Acquisition

28 Jul 2017 12:20

RNS Number : 4554M
Savills PLC
28 July 2017
 

SAVILLS ACQUISITION OF AGUIRRE NEWMAN

 

Further building the scale of Savills European real estate services business

 

Savills plc, one of the world's leading real estate advisory firms, announces the proposed acquisition of Aguirre Newman S.A. ("Aguirre Newman"), the leading Spanish independent real estate advisory business, for up to €67 million payable in instalments over five years from completion. The acquisition is scheduled to complete by 30th November 2017 following satisfaction of customary regulatory and closing conditions.

 

Aguirre Newman was founded in 1988. The business employs more than 400 staff and is headquartered in Madrid, with offices in Barcelona, Malaga, Lisbon and Porto (Portugal). The firm provides agency, investment, management, architectural, consultancy, valuation, planning, corporate finance and asset management services.

 

The businesses of Aguirre Newman and Savills in Spain will be integrated with Savills existing Spanish business employing 70 people in offices in Madrid and Barcelona, and will initially operate in Spain under the Savills Aguirre Newman brand. The principals of Aguirre Newman, Santiago Aguirre and Stephen Newman, and the Head of Savills Spain, Rafael Merry del Val, will be appointed to the Board of the combined businesses.

 

Commenting on the acquisition, Jeremy Helsby, Savills CEO, said: "The acquisition of Aguirre Newman combined with our existing Spanish business provides us with a significant footprint in Spain, a market where we see exciting long term growth opportunities. It follows Savills strategy to develop multi-service offerings and expand our presence in key Continental European markets."

 

For the year ended 31 December 2016, the gross turnover of the continuing operations of Aguirre Newman was €69 million.

 

The purchase consideration will be funded from Savills cash and existing banking facilities. On completion, Savills will pay €42 million. Deferred consideration of up to €5 million is payable on each anniversary of completion for the next five years totalling €25 million.

 

 

 

For further information please contact:

 

Savills

Jeremy Helsby, Chief Executive Officer, Tel: +44 20 7409 8934

Simon Shaw, Chief Financial Officer

 

Tulchan Communications Tel: +44 20 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKFDDDBKDOOB
Date   Source Headline
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.